ArticleClinical kidney journal2024

Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial.

Frederik Husum Mårup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.